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Abstract
Huntington’s disease (HD) is caused by polyglutamine expansion in huntingtin (htt) protein, but the exact mechanism of HD
pathogenesis remains uncertain. Recent evidence suggests that htt proteins with expanded polyglutamine tracts induce
endoplasmic reticulum (ER) stress, probably by interfering with ER-associated degradation (ERAD). Here we report that
mutant htt interacts and interferes with the function of gp78, an ER membrane-anchored ubiquitin ligase (E3) involved in
ERAD. Mapping studies showed that the HEAT repeats 2&3 of htt interact with the cue domain of gp78. The interaction
competitively reduces polyubiquitinated protein binding to gp78 and also sterically blocks gp78 interaction of p97/VCP, a
molecular chaperone that is essential for ERAD. These effects of htt negatively regulate the function of gp78 in ERAD and
are aggravated by polyglutamine expansion. Paradoxically, gp78 is still able to ubiquitinate and facilitate degradation of htt
proteins with expanded polyglutamine. The impairment of ERAD by mutant htt proteins is associated with induction of ER
stress. Our studies provide a novel molecular mechanism that supports the involvement of ER stress in HD pathogenesis.
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Introduction
Huntington’s disease (HD) is an inherited neurodegenerative
disorder that is caused by abnormal expansion of tri-nucleotide
CAG repeats in the first exon of the gene encoding huntingtin (htt)
protein [1–4]. The expanded CAG repeats are translated into
different lengths of polyglutamine tracts: expansions greater than
35 repeats induce HD disease [4,5], with the age of onset inversely
related to the length of the polyglutamine expansion [3,4].
Wild type htt protein is mostly localized in the cytoplasm with a
small proportion found in the nucleus [6]. Subcellular fraction-
ation studies have indicated that the protein is present in the
endoplasmic reticulum (ER), Golgi, plasma membrane, endocytic
and autophagic vesicles, endosomes, and mitochondria [6–13].
The function of htt protein is still unresolved. However, many
functions have been attributed to the protein including a role in
axonal transport, endocytosis, mitochondiral and vesicular traf-
ficking, and gene transcription [12,14–18]. The multitude of
its possible functions raises the possibility that polyglutamine
expansion might induce disease by interference of one or more of
these functions [4]. However, substantial evidence suggests that
the N-terminal htt fragments, harbouring the expanded polyglu-
tamine tract, are a chief trigger of toxicity, largely through a gain-
of-function mechanism [4,19]. Several proteases, including certain
caspases, calpain, and an unknown aspartic protease, cleave
mutant htt within the region spanning amino acids 513–552,
suggesting that these enzymes could play a role in disease
pathogenesis [4,20,21]. While definitive evidence for how
polyglutamine expansions in htt induce disease remains to be
established, a range of different mechanisms have been implicated,
including oxidative stress, transcriptional dysregulation, mitochon-
drial dysfunction, inhibition of the ubiquitin proteasome system
(UPS), excitotoxicity, and impairments of axonal transport and
synaptic transmission [4,22,23].
Recently, another mechanism that has gained attention is the
finding that mutant htt induce ER stress by interference with ER-
associated degradation (ERAD), the process by which misfolded
proteins in the ER are exported to the cytosol for degradation
by the proteasomes [24–29]. Complexes containing multiple
proteins are required for efficient ERAD. ER membrane-
anchored ubiquitin ligases (E3), an indispensible component of
the ERAD complexes, ubiquitinates misfolded ER proteins, thus
marking the proteins for elimination by proteasomes [30]. gp78
and Hrd1 are two well-characterized ER-localized E3s involved in
ERAD in mammalian cells [31–38]. The cytosolic domains of
gp78 and Hrd1 contain a RING finger domain that harbors the
E3 activity [31,39], as well as domains that recruit the AAA
ATPase protein, p97/VCP, to the ERAD complex [32–34]. p97/
VCP is an essentail factor that facilitates the dislocation of
polyubiquitinated ER proteins to the cytosol for degradation
[40,41]. The recent reports showed that mutant htt interacts with
p97/VCP and its cofactors Ufd1-Npl4 heterodimer and entraps
them in mutant htt aggregates, which impairs ERAD [26].
Impairment of the ERAD machinery has also been reported in
other neurodegenerative diseases. For example, mutant SOD1
(Superoxide dismutase 1), a protein mutated in familial Amyotro-
phic Lateral Sclerosis (ALS) disease, was shown to abnormally
interact with the Derlin1 protein, an essential ERAD component
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exported from the ER [42–44]. Mutant SOD1-Derlin1 interaction
results in inhibition of ERAD and causes ER stress-induced
neuronal degeneration [44]. ER stress-induced neuronal cell death
has been implicated in many other neurodegenerative diseases,
such as Parkinson’s disease, Alzheimer’s disease, prion disease, and
other polyglutamine diseases [26,44–46]. ER stress activates the
unfolded protein response (UPR), which triggers apoptosis by up-
regulation of CHOP/Gadd153 and activation of caspase-12,
caspase-9, and caspase-3 [47,48]. In addition, ER stress-induced
neuronal death via activation of the Ire1-TRAF2-Ask1-JNK
pathway has bee reported in models of ALS and in response to
polyglutamine toxicity [49,50].
We previously reported that Hrd1 ubiquitinates and targets
mutant htt for degradation [51]. In this study, we identified gp78
as another novel interacting partner of htt. We demonstrated an
interplay between mutant htt and gp78. Mutant htt compromises
gp78’s function in ERAD and triggers ER stress by directly
binding to the cue domain, which results in inhibition of gp78
interaction with polyubiquitinated proteins and p97/VCP. On the
other hand, gp78 ubiquitinats and enhances degradation of htt
proteins with expanded polyglutamine repeats, but does not affect
the degradation of htt proteins with normal polyglutamine repeats.
These results support the role of ER stress in pathogenesis of HD
and suggest that gp78 may play a protective role against mutant
htt toxicity.
Results
Overexpression of Mutant htt Stabilizes gp78 Protein,
Inhibits ERAD, and Induces ER Stress
Because mutant htt proteins have been found to induce ER
stress [26,27,29], we examined if gp78 that is involved in ERAD
might regulate htt-mediated toxicity. To test this possibility, we
examined whether overexpression of htt proteins containing
different number of polyglutamine repeats affects gp78 expression.
Increasing amounts of cDNA encoding the N-terminal 588 amino
acids fragment of htt containing either normal number (Nhtt17Q)
or pathogenic number of polyglutamine (Nhtt138Q) were
transfected into HEK293 cells. Sixteen hours later, the expression
levels of gp78 were monitored by immunoblotting. We found that
overexpression of both Nhtt17Q and Nhtt138Q led to a dose-
dependent increase of gp78 protein. The effects caused by
Nhtt138Q appeared to be more prominent, especially the slower
migrating forms of the protein (indicated as gp78* in Fig. 1A).
Previous studies have reported that the slower migrating forms
represent aggregated gp78 protein [31]. In addition, a time-course
study revealed a progressive accumulation of Nhtt17Q and
Nhtt138Q proteins over time (Fig. 1B). Interestingly, accumulation
of Nhtt138Q markedly increased accumulation of the aggregated
form of gp78, which was accompanied by a time-dependent
decrease of monomeric gp78 and an increase in induction of ER
stress as monitored by CHOP and BiP expression (Fig. 1B). The
correlation of gp78 aggregation with induction of ER stress
suggests that Nhtt138Q expression may compromise ERAD. In
support of this notion, cycloheximide chase experiments showed
that expression of either Nhtt-17Q or Nhtt138Q inhibits the
degradation of CD3d (Fig. 1C, D), a known substrate of gp78, but
Nhtt138Q inhibited more than that by Nhtt17Q. To exclude the
possibility that mutant htt regulates gp78 expression at the
transcriptional level, we examined expression of gp78 mRNA
by RT-PCR analysis and found that overexpression of neither
Nhtt17Q nor Nhtt138Q affected gp78 mRNA expression (Fig. 1E).
These results suggest that overexpression of mutant htt compro-
mises gp78 function in ERAD by causing accumulation of the
non-functional form of gp78.
gp78 Interacts with htt
We reasoned that the differential modulation of gp78
accumulation by htt proteins might arise from the differences in
interaction of the proteins. To test this possibility, FLAG-tagged
Nhtt17Q, Nhtt138Q, or ATF6 that was as a negative control,
were expressed in HEK293 cells and interaction of the proteins
was examined after immunoprecipitation of gp78. Immunoblot-
ting analysis revealed that Nhtt17Q and Nhtt138Q, but not ATF6
were co-immunoprecipitated with gp78 (Fig. 2A). Interestingly,
gp78 associated with more Nhtt138Q than Nhtt17Q, suggesting
that htt proteins with longer polyglutamine repeats bind more
strongly with gp78 than those with shorter polyglutamine repeats
(Fig. 2A). The increased association of Nhtt138Q with gp78 may
account for the increased aggregation of gp78 (Fig. 1A, B) leading
to more inhibition of CD3d degradation by Nhtt138Q than
Nhtt17Q as shown in Figure 1C and D. Because gp78 is an ER
resident protein, we next examined if overexpression of gp78
affects htt binding to the ER. Thus, Nhtt17Q and Nhtt138Q were
expressed individually, or co-expressed with gp78 in HEK293
cells. Transfected cells were then fractionated into cytosol and ER-
containing microsomal membrane fractions, and htt protein
partitioning in the two fractions was examined by immunoblotting.
The results showed that overexpression of gp78 increased the
amount of Nhtt17Q and Nhtt138Q that was present in
microsomes (Fig. 2B, C), indicating that gp78 recruits htt to the
ER membrane.
The results described above demonstrated that gp78 interacts
with overexpressed htt proteins. To establish that the interaction is
not an artifact of the overexpression of htt proteins, we examined
endogenous protein interaction in HEK293 cells. Indeed, we
found that endogenous htt was coprecipitated with gp78 (Fig. 2D).
Taking together, the results suggest that gp78 normally interacts
with htt proteins and that polyglutamine expansion enhances the
interaction of the proteins.
Htt, gp78, and p97/VCP Form a Trimeric Complex That Is
Disrupted by Polyglutamine Expansion
To explore how mutant htt proteins might inhibit ERAD, we
conducted additional immunoprecipitation experiments this time
focusing on p97/VCP, a known gp78-binding protein [32,52],
which plays a critical role in coupling ubiquitination, dislocation,
and proteasomal degradation of substrates during ERAD [53–55].
In these experiments, HEK293 cells were transfected with either
the Nhtt17Q expression construct or its empty vector, alone,
or cotransfected with gp78 cDNA after which p97/VCP was
immunoprecipitated and examined for coprecipitation of the
expressed proteins by immunoblotting. As shown in Figure 3A, a
small amount of Nhtt17Q was coimmunoprecipitated with p97/
VCP, with significantly more coimmunoprecipitation upon
overexpression of gp78, suggesting that gp78 is important
for mediating interaction of htt with p97/VCP (Fig. 3A). To
determine whether htt interacts directly with gp78 and p97/VCP
proteins, GST-pull down assays were performed using purified
recombinant proteins. In one set of incubations, GST-Nhtt17Q
was mixed with either purified 6-His-gp78 cytosolic tail (6-His-
gp78c) or 6-His-p97/VCP alone or 6-His-gp78c and 6-His-p97/
VCP proteins for 2 h at 4uC. A duplicate set of incubations was
made with GST instead of GST-Nhtt17Q as a negative control. As
shown in Figure 3B, 6-His-gp78c and 6-His-p97/VCP proteins
bound to GST-Nhtt17Q, but not to GST. Interestingly, more 6-
His-p97/VCP was pulled down by GST-Nhtt17Q from the
Huntingtin Binds to gp78
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effect seen by coimmunoprecipitation in cells (Fig. 3A). These
results suggest that htt, gp78, and p97/VCP form a trmieric
complex through direct interactions.
We next investigated whether htt proteins containing different
lengths of polyglutamine tracts affects binding of p97/VCP with
gp78. For these assays HEK293 cells were transfected with either
Nhtt17Q or Nhtt138Q expression constructs, or their empty
vector, followed by immunoprecipitation of gp78 from the cells
and immunoblotting for p97/VCP. The results revealed a
polyglutamine length-dependent reduction of coimmunoprecipita-
tion of p97/VCP with gp78 (Fig. 3C). These results suggest that
htt may regulate gp78 and p97/VCP interaction under physio-
logical conditions and that polyglutamine expansions might inhibit
gp78 and p97/VCP interaction.
A Region in HEAT 2 and HEAT 3 Repeats of htt Interacts
with the Cue Domain of gp78
To gain more insight into the molecular mechanism of
interaction between htt and gp78, we used GST pull-down assays
to map the binding site in each protein. The binding site of htt in
gp78 was mapped by incubating cell lysates prepared from
Nhtt17Q-expressing cells with GST-fusion proteins containing
different portions as well as mutated variants of gp78. As shown in
Figure 4A, Nhtt17Q binding was mapped to a region containing
the cue domain of gp78. We next determined the site of gp78
binding in htt protein. To do so, we transfected a series of
constructs encoding progressive C-terminal truncations of a
FLAG-tagged N-terminal 1-588 amino acid fragment of htt into
HEK293 cells and used lysates from the cells to examine if the
FLAG-tagged proteins bind GST, GST-gp78c, or GST-gp78-cue
Figure 1. Nhtt overexpression upregulates gp78 protein and induces gp78 aggregation. A. Nhtt upregulates gp78 protein in a dose-
dependent manner. Increasing amounts of Nhtt17Q and Nhtt138Q were expressed in HEK293 cells. Endogenous gp78 was examined by
immunoblotting. Actin was blotted as a loading control. gp78* indicates aggregated gp78. B. Accumulation of Nhtt138Q causes increased
aggregation of gp78 and induces ER stress. Equal amount of Nhtt17Q and Nhtt138Q were expressed in HEK293 cells. gp78, CHOP, and BiP were
assessed in these cells by immunoblotting. C, D. Nhtt inhibits CD3d degradation and polyglutamine expansion aggravates the inhibition. Nhtt17Q
and Nhtt138Q were transfected into HEK293 cells that stably express CD3d. CD3d degradation in transfected cells was analyzed by cycloheximide
(CHX) chase. D. Quantitative results of CD3d degradation are expressed as mean +/2 SD, n=3. After 2 hrs: vector vs. 17Q or 138Q, p,0.05; after 4 hrs:
vector vs. 17Q or 138Q, p,0.05; 17Q vs. 138Q, p,0.05, t-test. E. Neither Nhtt17Q nor Nhtt138Q affect gp78 mRNA expression. HEK293 cells expressing
Nhtt17Q or Nhtt138Q were examined by RT-PCR of gp78 mRNA. GAPDH mRNA was amplified as a control.
doi:10.1371/journal.pone.0008905.g001
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Figure 4B, the minimal N-terminal htt fragment that bound
GST-gp78c and GST-gp78-cue domain fusion proteins was the
amino acid 1-315 of htt, although binding of this fragment was
noticeably less than that mediated by the larger 1-472 and 1-588
fragments. By contrast to these fragments, no binding was
observed with htt fragments of amino acid 1-230, or smaller. An
examination of the amino acid sequence of the htt fragment
involved in gp78 binding revealed that it contains three HEAT
repeats (aa 206 to 243, 248 to 285, and 318 to 362), which we
considered as candidates for mediating gp78 binding. HEAT
repeats are thought to form a-helical bundles that appear to
function in protein-protein interaction [4]. We concentrated on
HEAT repeats 2 and 3, but not repeat 1, because the former, but
not latter were contained in htt fragments involved in gp78
binding. Accordingly, we analyzed whether purified 6-His-htt-aa
245–370 fusion protein that contains HEAT repeat 2 and 3 bind
GST-gp78-cue domain or GST. The results showed that 6-His-
htt-aa 245–370 binds to GST-gp78-cue domain and its mutant
(cue-m: two mutated ubiquitin-interacting residues - M467T and
L477D), but not GST (Fig. 4C). Collectively, these data suggest
that gp78 and htt bind directly through interactions between the
cue domain of gp78 and the HEAT 2 and 3 repeats of htt.
HttN Inhibits Polyubiquitin Binding to gp78
Previous reports have indicated the cue domain of gp78, which
is known to bind ubiquitin, is required for gp78 function in
ERAD [32,56,57]. Based on structural and bioinformatics
information of cue domain [58,59], we mutated three residues
(EML) that appeared to be involved in ubiquitin binding to
residues (STD, see Fig. 5A) that we considered would diminish,
but may not eliminate, ubiquitin binding (Fig. 5A, we called the
triple mutant Cue-m). To experimentally validate the effects of
t h e s em u t a t i o n s ,w ec o m p a r e dubiquitin binding between GST
proteins containing the wild-type gp78-cue domain with that of
the cue-m in pull-down assays. We also analyzed a more severely
crippled cue mutant of gp78 (mutated in six different positions,
called CD1/2 [56], see Fig 5A) that is devoid of ubiquitin
binding. As shown in Figure 5A, polyubiquitin binding to the
cue-m was significantly reduced, but was not abolished,
compared to the binding seen with the wild type and CD1/2
mutant proteins (Fig. 5A, upper panel).
Having established the polyubiquitin binding properties of the
three gp78-containing cue proteins, we next tested them for their
ability to bind Nhtt17Q protein by pull-down assays. These assays
revealed that the binding between Nhtt17Q and gp78 was
retained by the proteins containing either the intact or cue-m
version of the cue domain, but completely abolished in the cue-
CD1/2 mutant that is also unable to bind polyubiquitin chains
(Fig. 5B). These results suggest that the HEAT2 and 3 repeats may
bind to the same residues in the cue domain that are required for
ubiquitin interaction. To obtain evidence in support of this idea,
we asked whether htt inhibits ubiquitin-binding to the cue domain
in a competition experiment. In this experiment, His-tagged gp78c
was immobilized on Ni-NTA beads and incubated with a constant
amount of HEK293 cell lysate together with increasing amounts of
purified GST-Nhtt17Q. The beads were then washed and binding
of GST-Nhtt17Q and polyubiquitin was monitored by immuno-
blotting. As shown in Figure 5C, the amounts of polyubiquitin
pulled down by gp78c decreased upon addition of GST-Nhtt17Q,
Figure 2. gp78 interacts with htt. A. gp78 interacts with Nhtt and polyglutamine expansion increases the interaction. Nhtt17Q and Nhtt138Q
were expressed in HEK293 cells. FLAG-ATF6 and empty vector was used as controls. Immunoprecipitation was performed with anti-gp78 antibody
followed by immunoblotting with the antibodies as indicated. B, C. gp78 enhances Nhtt association with the microsomes. HEK293 cells fractionated
as indicated were subjected to fractionation into microsomal membranes (m) and cytosol (c). gp78 and Nhtt were detected by immunoblotting using
anti-gp78 and anti-FLAG antibodies. Calnexin was blotted as an ER marker. Microsome-associated Nhtt was expressed as a percentage of total Nhtt
associated with microsomes and in the cytosol (Mean 6 SD, n=3). D. Endogenous gp78 associates with htt. HEK293 cells were lysed in RIPA buffer
and gp78 was immunoprecipitated with anti-gp78 antibody clone 2G5. Endogenous htt was detected by immunoblotting.
doi:10.1371/journal.pone.0008905.g002
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with ubiquitin binding to gp78.
Because gp78 appeared to bind more Nhtt138Q protein than
with the Nhtt17Q protein (Fig. 2A, 3C), we suspected that
Nhtt138Q would hinder polyubiquitin interaction with gp78 more
efficiently compared with Nhtt17Q. To test this possibility,
lysates prepared from HEK293 cells expressing equal amount of
Nhtt17Q and Nhtt138Q were incubated with either GST-cue
protein or GST alone. The GST proteins were then affinity-
purified and the amount of polyubiquitin proteins that was
associated with the complex was analyzed by immunoblotting.
Consistent with our prediction, polyubiquitin binding to GST-cue
was diminished in a polyglutamine dependent manner (Fig. 6).
As expected, polyubiquitin did not bind to the GST alone.
Functionally, Nhtt138 also inhibits CD3d degradation more
efficiently than Nhtt17Q (Fig. 1C, D). These results are consistent
with the previous reports that polyubiquitin binding to the cue
domain of gp78 is essential for gp78’s function in ERAD [56,57].
Thus, the reduced binding of polyubiquitinated proteins to the cue
domain in httN138Q-containing lysates may be resulted from the
increased binding of httN to the cue domain due to polyglutamine
expansion.
Anti-Cue Domain Antibody Is Sufficient to Inhibit gp78
Binding to Polyubiquitin and p97/VCP
The preceding results suggested that interaction of htt with the
cue domain of gp78 leads to an obstruction in the binding of
polyubiquitin and p97/VCP to gp78, which is required for gp78
function in ERAD. To gain more insight into the mechanism of
the inhibition, we evaluated whether physical masking of the cue
domain with an antibody specific for the domain would like-
wise block polyubiquitin and p97/VCP binding to gp78. This
approach became feasible because of the properties of monoclonal
antibodies that we possessed. One of them, called 2G5 recognizes
an epitope between amino acids 497 to 578 of gp78, which is not
part of the cue domain. The antibody recognizes gp78, but does
discriminate between the wild type and CD1/2 cue mutant
proteins (Fig. 7A). A second monoclonal antibody called 1F1,
specific against the cue domain of gp78 (Fig. S1), differed in that it
fails to bind gp78CD1/2 protein (Fig. 7A). We utilized the two
antibodies to immunoprecipitate gp78 from cells, together with
an anti-HA antibody as a negative control, and probed the
precipitates to see whether p97 and ubiquitinated proteins were
coimmunoprecipitated. As shown in Figure 7B, gp78 was
precipitated by both 2G5 and 1F1 antibodies, but not by the
anti-HA antibody, as expected. Further blotting analysis of the
gp78 precipitated materials revealed that p97/VCP and poly-
ubiquitinated proteins were coimmunoprecipitated by the 2G5
antibody, but not by the 1F1 antibody (Fig. 7B). These results
suggest that, 1) inhibition of polyubiquitin binding is sufficient to
inhibit gp78-p97/VCP interaction, or 2) htt and anti-cue domain
antibody binding sterically blocks p97/VCP binding to its binding
site [the p97/VCP-Interacting Motif (VIM)] in gp78 [52]. To test
these possibilities, we expressed gp78CD/1/2 and wt gp78,
respectively, in HEK293 cells. Co-immunoprecipitation showed
that gp78CD1/2 binds to p97/VCP as well as wt gp78 (Fig. 7C).
Thus, polyubiquitin binding does not affect gp78-p97/VCP
interaction, supporting the idea that htt binding to cue domain
not only inhibits ubiquitin binding but also sterically blocks the
access of VIM to p97/VCP.
gp78 Promotes Nhtt138Q Degradation
We previously reported that the gp78-related E3 Hrd1
ubiquitinates and facilitates mutant htt degradation [51].
Physical interaction between gp78 and htt prompted us to
investigate whether gp78 plays a similar role. First, we evaluated
whether overexpression of gp78 affects the steady-state accumu-
lation of htt. Nhtt17Q or Nhtt138Q was co-transfected with
i n c r e a s i n ga m o u n t so fg p 7 8i n t oH E K 2 9 3c e l l s .F i g u r e8 A
Figure 3. gp78 forms a complex with Nhtt and p97/VCP and
Nhtt138Q disrupts gp78-p97/VCP interaction. A. gp78 enhances
Nhtt17Q interaction with p97/VCP. HEK293 cells transfected as
indicated were processed for IP for p97/VCP. Immunoprecipitates were
blotted for the indicated proteins. B. Formation of trimeric complex of
GST-Nhtt17Q, gp78c, and p97/VCP. GST-Nhtt17Q immobilized on beads
was incubated with purified 6-His-p97/VCP and 6-His-gp78c. After
washing, GST-Nhtt17Q-associated gp78c and p97/VCP were detected
by immunoblotting. C. Nhtt inhibits gp78 interaction with p97/VCP and
polyglutamine expansion aggravates the inhibition. HEK293 cells
transfected as indicated were processed for immunoprecipitation for
gp78. Precipitates were blotted for the indicated proteins.
doi:10.1371/journal.pone.0008905.g003
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reduction in Nhtt138Q levels, butd i dn o ta f f e c tN h t t 1 7 Ql e v e l s .
To examine whether endogenous gp78 regulates htt levels, we
used RNA interference to reduce gp78 expression. siRNA
specific for gp78 was transfected into HEK293 cells that
express Nhtt17Q or Nhtt138Q. siRNA that does not target any
known gene was transfected as a negative control. Immunoblot-
ting revealed that gp78 was efficiently knocked down by the
appropriate siRNA, and this correlated with a noticeable
increase in Nhtt138Q accumulation and almost no change
in Nhtt17Q accumulation, as compared with the control
siRNA-transfected cells (Fig. 8B). These data suggest that gp78
preferentially facilitates mutant htt degradation.
We next studied the consequence of overexpression of wild type
and an E3 inactive mutant of gp78 on the turnover of Nhtt138Q
protein by cycloheximide chase experiments. Thus, Nhtt138Q
was co-expressed in HEK293 cells with vector control, wt gp78,
or gp78R2m, an E3-inactive mutant gp78 [31]. 24 hour after
Figure 4. The cue domain of gp78 interacts with the HEAT 2 & 3 repeats of htt. A. The cue domain of gp78 is responsible for its interaction
with htt. Left: Diagram shows GST-gp78c and its truncation mutants used in pull down assay. Right: GST-gp78c and its truncation mutants were
incubated with HEK293 cell lysates expressing Nhtt17Q. The Nhtt17Q associated with GST-gp78 was detected with anti-FLAG antibody. GST fusion
proteins were stained by ponceau s red. B. The cue domain of gp78 interacts with a region containing the HEAT 2&3 repeats of htt. HEK293 cell
lysates expressing various Nhtt truncation mutants containing 17Q were subjected to GST pull down experiment with GST-gp78c and its mutants.
Nhtt mutants were detected by immunoblotting. C. Direct interaction of the cue domain of gp78 and the HEAT 2&3 repeats. Recombinant 6His-
tagged HEAT 2&3 protein was incubated with GST, GST-cue domain or a GST-Cue domain mutant (Cue-m, see Figure 5A for detailed amino acid
changes). Binding of HEAT 2&3 was detected by immunoblotting for 6-His. GST and its fusion proteins were stained by ponceau s red.
doi:10.1371/journal.pone.0008905.g004
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protein synthesis and the turnover of Nhtt138Q was analyzed by
immunoblotting of the cell lysates collected at 0, 5, and 10 h. As is
evident from Figure 8C & D, overexpression of wt gp78 but not
gp78R2m enhanced Nhtt138Q degradation, indicating that gp78
E3 activity is critical for promoting Nhtt138Q degradation. We
then examined whether gp78 enhances Nhtt138Q ubiquitination.
HEK293 cells were transfected as in Figure 8C and Nhtt138Q was
immunoprecipitated from SDS-denatured cell lysates. Precipitates
were processed for immunoblotting with anti-ubiquitin antibody.
As expected, co-expression with wt gp78 but not gp78R2m
increased polyubiquitination of Nhtt138Q. In contrast, overex-
pression of wt gp78 or gp78CD1/2 had no effects on either
ubiquitination or degradation of Nhtt17Q (Fig. S2). These results
suggest that gp78 acts as an E3 and selectively targets mutant htt
for degradation.
Figure 5. Htt588 inhibits polyubiquitinated protein binding to gp78. A. Effects of cue domain mutation on polyubiquitin binding. GST
fusions of two different cue domain mutants: cue-m and gp78cCD1/2(aa309-643), and their corresponding wt controls, cue and gp78c(aa309–643),
were immobilized on beads and incubated with increasing amounts of lysates prepared from HEK293 cells. After washing, polyubiquitinated proteins
associated with these GST fusion proteins were examined by immunoblotting for ubiquitin. B. gp78c-CD1/2 fails to bind both Nhtt17Q and
polyubiquitin. GST fusion proteins as indicated were incubated with HEK293 cell lysates prepared from HEK293 cells transfected with Nhtt17Q.
Polyubiuitinated proteins and Nhtt17Q were detected by immunoblotting. C. Nhtt17Q dose-dependent inhibition of polyubiquitinated protein
binding to 6-His-gp78c. Beads-immobilized 6-His-gp78c was incubated with HEK293 cell lysates or along with increasing amounts of purified GST-
Nhtt17Q. After washing, beads-associated polyubiquitin and GST-Nhtt17Q were determined by immunoblotting.
doi:10.1371/journal.pone.0008905.g005
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with htt, we next examined whether an intact cue domain is
required for Nhtt138Q degradation. Accordingly, Nhtt138Q was
co-transfected with vector, wt gp78, or the gp78CD1/2 cue
domain mutant that does not bind to Nhtt138Q and the turnover
of Nhtt138 compared by cycloheximide chase experiments. As
shown in Figure 8F-H, overexpression of gp78CD1/2 failed to
promote Nhtt138Q ubiquitination and degradation compared
to that seen with the wild type gp78 protein. Collectively, these
observations suggest that gp78 functions to promote mutant htt
degradation.
Discussion
ER stress is triggered when the production of misfolded proteins
in the ER exceeds the capacity of the organelle to refold or dispose
the misfolded proteins [46,60,61]. The disposal of misfolded
proteins from the ER is achieved by ERAD, the main pathway by
which misfolded proteins are exported to the cytosol for
degradation by proteasomes [62]. In this report we demonstrate
that polyglutamine expansions in htt proteins induce ER stress by
interfering with the function of gp78, an ER resident E3 that
normally functions in ERAD. Our findings suggest that perturba-
tion of gp78 function occurs by three interrelated mechanisms: 1)
polyglutamine expansion enhances mutant htt interaction with the
cue domain of gp78, thereby severely hindering polyubiquitin
binding to the cue domain; 2) mutant htt sterically blocks p97/
VCP interaction with gp78; 3) accumulation of mutant htt causes
aggregation of gp78. In addition, we showed that gp78 is able to
ubiquitinate and enhance mutant htt degradation. This function
makes gp78 vulnerable when mutant htt accumulates and
aggregates during HD progression.
The function of ERAD complexes is centered on ER
membrane-spanning RING finger ubiquitin ligases, such as
gp78, Hrd1, and RMA1 [31,33,34,39,63]. The RING finger of
these E3s and the protein degradation machinery, proteasomes,
are both localized on the cytosolic surface of the ER [30,51,62].
This spatial arrangement is thought to facilitate the coupling of
machineries required for ubiquitination and retrotranslocation of
ER substrates with proteasomal degradation. The arrangement
also permits the complex to function in the disposal of misfolded
proteins that normally reside in the cytosol. This dual role could
have consequences for a cell because selection of a cytosolic
substrate over a ER substrate by the ERAD complex could lead to
a build up of misfolded proteins in the ER, especially when the
cytosolic substrate is hard to be degraded.
The involvement of ER resident E3 in degradation of cytosolic
substrates is illustrated by the interaction and degradation of
mutant htt by Hrd1 [51]. Similarly, recent studies have shown that
gp78 is able to enhance degradation of mutant SOD1 and ataxin-
3 proteins [64]. Interestingly, mutant SOD1 also inhibits ERAD
by interacting with Derlin1, a protein implicated as forming the
channel through which misfolded proteins are dislocated from the
Figure 6. Effects of Nhtt17Q and Nhtt138Q on polyubiquiti-
nated protein binding to the cue domain of gp78. Nhtt138Q
inhibits polyubiquitin binding to gp78 more than Nhtt17Q. Lysates
prepared from HEK293 cells expressing equal amount of Nhtt138Q and
Nhtt17Q were used in GST-cue pull down assay. Association of
polyubiquitinated proteins with GST or GST-cue was determined by
anti-ubiquitin blotting.
doi:10.1371/journal.pone.0008905.g006
Figure 7. Anti-cue domain antibody fails to co-immunoprecip-
itate p97/VCP and polyubiquitinated proteins. A. Monoclonal
anti-gp78 antibody clone 1F1 does not recognize gp78CD1/2. HEK293
cells expressing wt gp78 and gp78CD1/2 were subjected to immuno-
blotting with anti-gp78 antibody clone 2G5 and 1F1, respectively. B. 1F1
precipitates gp78 but not p97/VCP and polyubiquitinated proteins.
gp78 was immunoprecipitated from HEK293 cell lysates with 2G5 and
1F1, respectively. Co-immunoprecipitation of p97/VCP and polyubiqui-
tinated proteins was examined by immunoblotting. C. gp78CD1/2
interacts with p97/VCP but not polyubiquitinated proteins. HEK293 cells
transfected with wt gp78 or gp78CD1/2 was processed for immuno-
precipitation with 2G5 antibody.
doi:10.1371/journal.pone.0008905.g007
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PLoS ONE | www.plosone.org 8 January 2010 | Volume 5 | Issue 1 | e8905Figure 8. gp78 ubiquitinates and targets Nhtt138Q but not Nhtt17Q for degradation dependent on its RING finger and cue domain.
A. Overexpression of gp78 decreases the levels of Nhtt138Q but not Nhtt17Q protein. Increasing amounts of gp78 were expressed in HEK293 cells
that had been transfected with Nhtt17Q or Nhtt138Q. 24 h after gp78 transfection, cells were processed for immunoblotting for the indicated
proteins. B. Knockdown of gp78 stabilizes Nhtt138Q but not Nhtt17Q. gp78 was knocked down by RNAi in HEK293 cells expressing Nhtt138Q or
Nhtt17Q. 2 days after the knockdown cells were processed for immunoblotting for gp78 and Nhtt17Q and Nhtt138Q. Actin was blotted as a loading
control. C. gp78 enhances Nhtt138Q degradation, which requires an intact RING finger. HEK293 cells transfected as indicated were subjected to
cycloheximide (CHX) chase. Nhtt138Q degradation was quantified and expressed as mean +/2 SD, n=3, in D. E. gp78 ubiquitinates Nhtt138Q.
Nhtt138Q-expressing HEK293 cells were transfected with wt gp78, or gp78R2m, or empty vector as a control. Nhtt138Q was immunoprecipitated
with anti-FLAG antibody. Precipitates were processed for immunoblotting for ubiquitin. F - H. Cue domain is required for gp78 to ubiquitinate and
target Nhtt138Q for degradation. Wt gp78, gp78CD1/2, or empty vector-transfected HEK293 cells were subjected to analysis as described in C–E.
doi:10.1371/journal.pone.0008905.g008
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as we now demonstrate that gp78 promotes degradation of mutant
htt. These data strongly support that ER-anchored E3 containing
complexes play a quality control role not only for ER proteins,
but also for non-ER proteins that are accessible from the cytosol
as suggested previously [51]. As a response to accumulation of
misfolded ER proteins, the expression of gp78 is increased
by accumulation of neurodegenerative disease proteins, such as
mutant htt, SOD1, and ataxin-3 [64]. This may represent a
protective response to enhance the removal of these disease
proteins. Indeed, gp78 not only facilitates the degradation of
mutant htt, it also enhances the clearance of mutant SOD1 and
ataxin-3 [64]. This is similar to the apparent broad specificity of
ERAD E3s in targeting different proteins in the ER for
degradation. On the other hand, a particular substrate can be
degraded by multiple E3s. This is evident by the fact that mutant
htt proteins can be degraded by either gp78 (this study) or Hrd1
[51]. We speculate that the apparent promiscuous substrate
specificity of gp78 (and possibly other E3s) for the different
neurodegenerative proteins would negatively impact ERAD
because of the inefficiency in degradation of misfolded disease
proteins. For example, mutant htt accumulates and gradually
aggregates in neurons during HD progression, probably because
the rate of mutant htt degradation is slower than the rate of
its production/accumulation. The inefficiency in degradation of
mutant htt proteins would preoccupy E3 proteins like gp78 and
Hrd1 that might typically engage in ERAD in a futile effort
toward degrading mutant htt proteins. We speculate that this non-
productive interaction might lead to an accumulation of misfolded
proteins in the ER leading to ER stress. This is supported by the
fact that accumulation of mutant htt causes marked aggregation of
gp78 protein while reduces monomeric gp78, which correlates
with increased ER stress (Fig. 1B). gp78 aggregation is expected to
diminish its function in ERAD.
In this study, we mapped the interaction between mutant htt
and gp78 to the HEAT 2&3 repeats of htt and the cue domain of
gp78. Htt with partial truncation of HEAT 3 still bound gp78
albeit to a lesser extent than a htt fragment with both HEAT 2 and
3 repeats. However, due to the insolubility of HEAT 2 fragment,
we were not able to determine whether HEAT 2 is sufficient for
binding to the cue domain. The region of htt that is involved in
gp78 binding is consistent with our findings that N-terminal htt
fragments bind gp78 irrespective of the number of polyglutamine
repeats (i.e. both Nhtt17Q and Nhtt138Q bind gp78). The
importance of this interaction is strengthened by our findings that
endogenous htt was co-immunoprecipitated with endogenous
gp78, suggesting it might serve a regulatory role for gp78. Future
studies will be directed to study the functional importance of gp78
and htt interaction. Our results suggest that htt, gp78, and p97/
VCP may form a ternary complex. However, p97/VCP forms
hexamer and gp78 has also been shown to form a large oligomer
[65]. Whether or not the ternary complex forms in cells may
depend on the relative amounts of the proteins and may be
subjected to regulation. This may partially explain why httN
overexpression disrupted gp78-p97/VCP interaction in cells.
The cue domain of gp78 is well known for its ability to bind
ubiquitin [32,56,57]. We found that htt and ubiquitin may share
the same binding residues in the cue domain. This is supported by
the fact that mutation of the residues in the cue domain that are
known for ubiquitin interaction results in loss of htt binding.
Furthermore, htt competes with polyubiquitin binding to the cue
domain. In addition, htt binding appears to sterically block p97/
VCP binding to gp78, which is supported by our studies showing
an anti-cue domain antibody also appears to inhibit gp78 binding
to polyubiquitin and p97/VCP. These results lead us to speculate
that htt may be normally a negative regulator of gp78 function.
However, this regulatory function is exaggerated by polygluta-
mine expansion because mutant htt enhances htt binding to gp78
leading to severer inhibition of gp78 interaction with polyubiqui-
tin and p97/VCP, which may explain at least partially the
inhibitory effects of mutant htt on ERAD. Paradoxically, despite
interference of p97/VCP binding to gp78, mutant htt proteins
are still degraded by gp78, albeit inefficiently. This might not
be surprising because p97/VCP binding is principally thought
to be required for providing the driving force for dislocation
of substrates form the ER and might not be essential for gp78-
mediated degradation of cytosolic substrates like mutant htt
proteins. However, we cannot rule out the possibility that
p97/VCP may act as a chaperone in the cytosol to deliver
ubiquitinated mutant htt for degradation.
gp78 selectively targets Nhtt588-138Q but not Nhtt588-17Q for
degradation, suggesting that polyglutamine expansion-induced
misfolding renders htt a substrate for gp78. But recognition of
misfolded htt by gp78 still requires the cue domain, since mutation
of the cue domain that abrogates gp78-htt interaction failed to
target mutant htt for degradation. Interestingly, the cue domain of
gp78 has been previously reported to recognize another substrate,
DF508CFTR [57,66]. The finding that the HEAT 2&3 repeats
provide a recognition site for gp78 might help explain why
polyglutamine-expanded htt exon-I fragment that is widely used
for studying mutant htt toxicity and lacks HEAT repeats 2&3, is
not a substrate for gp78 as described in this study and reported
recently by others [64]. However, our results do not distinguish
whether mutant htt proteins lacking HEAT repeats 2&3 might
interfere with normal gp78 function at different stage of HD. For
example, recent studies reported that polyglutamine-expanded
exon I entraps the p97/VCP-Ufd1-Npl4 complex in its aggregates
and impairs ERAD [26]. Because the critical role of p97/VCP in
gp78-mediated ERAD, the entrapment of p97/VCP in htt exon-I
aggregates is expected to be detrimental to gp78 function. Taking
together, our results provide novel insights into the role that gp78
might play in the turnover and pathogenicity of normal and
mutant htt proteins.
Materials and Methods
Plasmids and Antibodies
cDNA encoding aa309-643 of gp78 was cloned into the pET-
28a(+) vector to make pET28a(+)gp78c. cDNA encoding HEAT
2&3 (aa245–370) of human htt was cloned into pET28a(+) vector
to generate pET28a(+)-HEAT 2&3 through BamHI and HindIII
sites. cDNA encoding aa435-507 of mouse gp78 was cloned into
pGEX4T1 vector to produce pGEX4T1-gp78-cue via BamHI
and NotI sites. pGEX4T1-gp78-cue-m was generated by site-
directed mutagenesis on pGEX4T1-gp8-cue. pCIneo-gp78CD1/2
is a generous gift from Dr. Allan M. Weissman [56]. The following
are a list of plasmids that have been previously reported
[32,51,67]: pQE9-p97/VCP, pCIneo-gp78, pCIneo-gp78R2m;
pCI 3X Flag-Nhtt-588aa-17Q and pCI 3X Flag-Nhtt-588aa-
138Q, pCI 3X Flag-Nhtt-120aa-17Q, pCI 3X Flag-Nhtt-230aa-
17Q, pCI 3X Flag-Nhtt-315aa-17Q, pCI 3X Flag-Nhtt-472aa-
17Q, pGEX4T-htt588aa; pGEX4T2-gp78C and its mutants.
Mouse monoclonal antibodies against HA, FLAG, and actin
were purchased from Sigma. Mouse monoclonal anti-ubiquitin
and anti-huntingtin antibodies were acquired from Santa Cruz
Biotechnologies Inc. Monoclonal anti-p97/VCP was obtained
from Affinity Bioreagents. Monoclonal anti-gp78 antibody clone
2G5 was reported previously [52] and clone 1F1 was recently
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siRNA targeting gp78 was previously described [32].
Cells Culture and Transfection
HEK293 cells were cultured in DMEM (Dulbecco’s modified
Eagle’s medium) supplemented with 10%(V/V) fetal bovine
serum, 50 units/ml penicillin, 50 ug/ml streptomycin and
Glutamine under 5% CO2 in a humidified incubator. Transient
transfections were performed using Lipofectamine 2000 (Invitro-
gen) or Calcium phosphate precipitation. HA-CD3 stable cell line
has been described previously [52].
Recombinant Proteins and GST-Pull-Down Assay
Bacterially expressed recombinant GST fusion proteins and 6-
His-tagged proteins were produced as reported previously [32].
For mapping the huntingtin interaction site with gp78, we
first immobilized 2 mg of each GST-gp78c(aa309–643) and its
truncation mutants on glutathione-sepharose beads. Then we
prepared lysates from cells transfected with FLAG-Nhtt17Q
using lysis buffer containing 150 mM NaCl, 20 mM Tris/HCl,
pH 7.5, 1 mM EDTA, and 0.5% NP-40. Beads-immobilized
GST-gp78c and its mutants were incubated with FLAG-
Nhtt17Q-containing lysates at 4uC for 2 h. After washing with
the lysis buffer for 3 times, beads-bound Nhtt17Q was examined
by immunoblotting. To map gp78 binding site on htt, HEK293
cells were transfected with plasmids encoding various truncation
mutants of htt tagged with FLAG as described in Figure 4B.
Lysates were prepared from these cells and incubated with beads-
immobilized GST-gp78c or GST-cue domain at 4uCf o r2h .
GST pull-down of polyubiquitinated proteins was performed
similarly as described above. Direct interactions among gp78,
htt, and p97/VCP were carried out using purified recombinant
proteins and the binding procedure has been reported previously
[52].
Immunoblotting and Immunoprecipitation
Immunoblotting procedure used is essentially the same as we
reported previously [52]. HEK293 cells were seeded at 6610
5 per
well in 6-well plates prior to the day of transfection. Transfection
was done with lipofectamine 2000 (Invitrogen) or by calcium
phosphate precipitation. Twenty-four hours after transfection, cells
were lysed in 2% SDS by boiling for 10 minutes. The resulted
lysates were used for blotting of total proteins. To evaluate the
effects of gp78 on degradation of Nhtt, 100 mg/ml cycloheximide
(CHX) was added to the medium sixteen to twenty hours after
transfection and the cells were subject to chase for 0, 5, and
10 hours before being processed for immunoblotting to detect the
indicated proteins.
To determine protein-protein interactions by co-immunopre-
cipitation, HEK293 cells transfected as indicated in figures were
lysed in buffer containing 150 mM NaCl, 20 mM Tris, pH 8.0,
5 mM EDTA, 0.5% NP40 and 1X protease inhibitor cocktail.
The lysates were then clarified by centrifugation. The resulted
supernatants were used for immunoprecipitation followed by
immunoblotting as described in figure legends. For endogenous
protein interaction, co-immunoprecipitation was done in HEK293
cell lysates without any transfection.
To assess if gp78 mediates ubiquitination of mutant htt in cells,
HEK293 cells were co-transfected with plasmids encoding at
gp78, gp78R2m, or gp78CD1/2 along with FLAG-Nhtt17Q or
-Nhtt138Q. Twenty-four hours after transfection, cells were lysed
in RIPA buffer (1X PBS, 1% Nonidet P-40, 0.5% sodium
deoxycholate, and 10 mg ml phenylmethylsulfonyl fluoride)
containing 1% SDS plus brief sonication. The lysates were
clarified by centrifugation at 14,000 rpm at 4uC for 15 minutes
and supernatants were diluted with 1X PBS to a final
concentration of 0.2% SDS. FLAG-Nhtt was immunoprecipitated
with anti-FLAG antibody using protein A-Sepharose beads. The
ubiquitinated Nhtt was determined by immunoblotting for
ubiquitin.
To assess the effects of gp78 on Nhtt-membrane association,
HEK293 cells were co-transfected with gp78 and FLAG-Nhtt17Q
or -138Q. Sixteen hours after transfection, cells were fractionated
into microsomal and cytosolic fractions as previously reported.
Microsomes and cytosol were further processed for immunoblot-
ting as previously described [51].
RT-PCR
293 cells were transfected with plasmids encoding FLAG-
Nhtt17Q, -138Q, or empty vector as a negative control. Twenty-
four hours after transfection, total RNA was extracted from
transfected cells using TRIzol Reagent (Invitrogen) following the
protocol provided by the manufacturer. RT-PCR was done as
reported previously [51].
Supporting Information
Figure S1 Mapping epitope for monoclonal anti-gp78 antibody
clone 1F1 and 2G5. GST fusions of various truncations of the
cytosolic tail (aa309–643) were processed for immunoblotting with
monoclonal anti-gp78 antibody clone 1F2 or 2G5. Upper panel:
diagramatic representation of GST fusions of gp78 mutants and
summary of antibody reactions. Lower panel: 1F1 and 2G5
immunoblots.
Found at: doi:10.1371/journal.pone.0008905.s001 (0.17 MB TIF)
Figure S2 gp78 does not affect ubiquitination and degradation
of Nhtt588-17Q. A. HEK293 cells transfected as indicated were
subjected to cycloheximide (CHX) chase. B. gp78 ubiquitinates
Nhtt17Q. Nhtt17Q-expressing HEK293 cells were transfected
with wt gp78, or gp78CD1/2, or empty vector as a control.
Nhtt17Q was immunoprecipitated with anti-FLAG antibody.
Precipitates were processed for immunoblotting for ubiquitin.
Found at: doi:10.1371/journal.pone.0008905.s002 (0.18 MB TIF)
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